Versions :<123Live>

CDC Panel Votes to Limit MMRV Vaccine for Young Children

CDC Panel Votes to Limit MMRV Vaccine for Young Children
Image copyright: 

The Spin

These changes represent a long-overdue correction to vaccine policies that prioritize pharmaceutical profits over genuine safety concerns. The MMRV decision simply aligns recommendations with what most parents already choose — separate shots that reduce seizure risks for vulnerable toddlers. Kennedy's committee is finally asking the hard questions about why America pushes more vaccines on newborns than other developed nations, especially when safer alternatives exist.

This represents a dangerous erosion of evidence-based medicine that will leave children vulnerable to preventable diseases. The committee ignored decades of safety data and expert input to make politically motivated decisions that could reduce vaccination rates and insurance coverage. These changes target vaccines that have successfully protected millions of children, with the hepatitis B birth dose alone preventing 99% of acute infections in young children since 1991.


The Controversies



Articles on this story



© 2025 Improve the News Foundation. All rights reserved.Version 6.15.2

© 2025 Improve the News Foundation.

All rights reserved.

Version 6.15.2